NASDAQ: LTRN
Lantern Pharma Inc Stock Ownership - Who owns Lantern Pharma?

Insider buying vs selling

Have Lantern Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Leslie W. Kreis10% Owner2025-06-1312,319$3.09
$38.07kSell
Leslie W. Kreis10% Owner2025-06-131,903$3.09
$5.88kSell
Leslie W. Kreis10% Owner2025-06-1314,218$3.09
$43.93kSell
Leslie W. Kreis10% Owner2025-06-134,354$3.09
$13.45kSell
Leslie W. Kreis10% Owner2025-06-137,206$3.09
$22.27kSell
Aaron Gl Fletcher10% Owner2025-06-134,354$3.09
$13.45kSell
Aaron Gl Fletcher10% Owner2025-06-1314,218$3.09
$43.93kSell
Aaron Gl Fletcher10% Owner2025-06-131,903$3.09
$5.88kSell
Aaron Gl Fletcher10% Owner2025-06-1312,319$3.09
$38.07kSell
Aaron Gl Fletcher10% Owner2025-06-137,206$3.09
$22.27kSell

1 of 8

LTRN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LTRN insiders and whales buy or sell their stock.

LTRN Shareholders

What type of owners hold Lantern Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Leslie W. Kreis27.44%2,958,970$9.44MInsider
Bios Capital Management LP11.20%1,207,709$3.85MInstitution
Aaron Gl Fletcher9.98%1,075,952$3.43MInsider
David S. Silberstein9.68%1,044,000$3.33MInsider
Biological Mimetics Inc9.68%1,044,000$3.33MInsider
Arunkumar Asaithambi4.10%441,960$1.41MInsider
Vanguard Group Inc3.37%363,720$1.16MInstitution
CM Management LLC1.85%200,000$638.00kInstitution
Green Park Golf Ventures II LLC1.22%131,697$420.11kInsider
Geode Capital Management LLC0.84%90,504$288.71kInstitution

1 of 3

LTRN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LTRN22.47%62.09%Net SellingNet Selling
JUNS1.14%0.10%
KZR21.41%78.59%Net Selling
ESLA1.70%82.00%
LVTX30.58%38.47%

Lantern Pharma Stock Ownership FAQ

Who owns Lantern Pharma?

Lantern Pharma (NASDAQ: LTRN) is owned by 22.47% institutional shareholders, 62.09% Lantern Pharma insiders, and 15.43% retail investors. Leslie W. Kreis is the largest individual Lantern Pharma shareholder, owning 2.96M shares representing 27.44% of the company. Leslie W. Kreis's Lantern Pharma shares are currently valued at $9.35M.

If you're new to stock investing, here's how to buy Lantern Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.